Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-03-24

Clinical Trial Update: Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tramadol hydrochloride with dexketoprofen trometamol for moderate to severe acute pain after removal of impacted lower third molars; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tramadol hydrochloride and dexketoprofen trometamol combination

Snippet

Sponsor: Menarini Group | Conditions: Acute Pain | Phase 4 | Status: COMPLETED | Results posted: 2021-03-24